title: Systemic illness with skin eruption, fever and positive lymphocyte transformation test in a patient on irbesartan.
authors.forename: S
authors.initials: S
authors.lastname: Constable
authors.forename: J
authors.initials: J
authors.lastname: Farrell
authors.forename: D
authors.initials: D
authors.lastname: Naisbitt
authors.forename: C
authors.initials: C
authors.lastname: King
authors.forename: N
authors.initials: N
authors.lastname: Leonard
authors.forename: M
authors.initials: M
authors.lastname: Pirmohamed
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D000077405:Irbesartan; D007868:Leg Dermatoses / Q000139:chemically induced; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan